CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BlossomHill Therapeutics Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BlossomHill Therapeutics Inc
10255 Science Center Drive, Suite 200
Phone: (858) 732-3880p:858 732-3880 SAN DIEGO, CA  92121  United States Ticker: BLSMBLSM

Business Summary
BlossomHill Therapeutics, Inc., founded in 2020, is a biotechnology company focused on the design and development of small molecule medicines for treating cancer and autoimmune diseases.
(Source: PRESS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/202612/31/2025YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Chairman of the Board YishanLi 61 6/1/2020 6/1/2020
President, Chief Executive Officer, Director JingrongCui 63 6/1/2020 6/1/2020
Chief Financial Officer, Executive Vice President JasonKeyes 55 5/9/2025 5/9/2025
7 additional Officers and Directors records available in full report.

Business Names
Business Name
BLOSSOMHILL THERAPEUTICS INC
BLSM

General Information
Number of Employees: 69 (As of 6/30/2026)
Outstanding Shares: 31,784,909 (As of 9/16/2026)
Stock Exchange: NASD
Federal Tax Id: 851578711
Fax Number: (302) 645-1280
Email Address: info@bhtherapeutics.com


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, October 24, 2026